Concentrated solution of Bovine Serum Albumin (BSA) conjugated to Tacrolimus (FK506). A carbon spacer arm of 19.0 Å links BSA to the Tacrolimus moiety. Each BSA molecule contains several Tracrolimus units. Dilutions of the provided conjugate can be made in 1X Phosphate Buffer Saline, pH 7.4.
Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am – 8 pm PST)
Brunet, M., Plana, J. C., and Rimola, A. (2001). Tacrolimus. Madrid: Drug Farma.
Goto, T., and Nakagawa, H. (2004). Development of Tacrolimus Ointment. Tacrolimus Ointment, 81–98.
Raptis, D., and Pramateftakis, M.-G. (2013). Tacrolimus: Effectiveness, safety and drug interactions. New York: Nova Biomedical.
Plosker, G. L., and Foster, R. H. (2001). Tacrolimus a further update of its pharmacology and therapeutic use in the management of organ transplantation. Auckland: ADIS International.
Kaplan, B., Burckart, G. J., and Lakkis, F. G. (2012). Immunotherapy in transplantation: principles and practice. Chichester, West Sussex, UK: Wiley Blackwell.
Oberbauer R, Bestard O, Furian L, Maggiore U, Pascual J, Rostaing L, Budde K. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant Rev (Orlando). 2020 Jan 13:100531.